Advertisement


Charles L. Loprinzi, MD, on Olanzapine for Prevention of CINV

2015 Palliative Care in Oncology Symposium

Advertisement

Charles L. Loprinzi, MD, of the Mayo Clinic, discusses olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (Abstract 176).



Related Videos

Symptom Management
Palliative Care

Lawrence H. Einhorn, MD, on CINV Clinical Trial Results: The Alliance A221301 Study

Lawrence H. Einhorn, MD, of Indiana University Simon Cancer Center, discusses the encouraging study findings on olanzapine for prevention of chemotherapy-induced nausea and vomitin...

Palliative Care

Jennifer S. Temel, MD's Expert Perspective: Palliative Care in 2015

As Steering Committee Chair of this year’s symposium, Jennifer S. Temel, MD, of Massachusetts General Hospital, discusses the goals and highlights of the meeting.

Palliative Care

Kathleen Foley, MD, on Palliative Care in Low-Resource Settings

Kathleen Foley, MD, of Memorial Sloan Kettering Cancer Center, discusses the challenges of integrating palliative care in areas without sufficient resources or health-care infrastr...

Palliative Care
Symptom Management

Eduardo Bruera, MD, on Cachexia Assessment and Management State of the Art

Eduardo Bruera, MD, of The University of Texas MD Anderson Cancer Center, discusses exciting developments in the assessment and management of cachexia, as well as a number of emerg...

Pain Management

Judith Paice, PhD, RN, on Neuropathic Pain

Judith Paice, PhD, RN, of Northwestern University, reviews the current principles on assessing and treating neuropathic pain in cancer.

Advertisement

Advertisement



Advertisement